Cholinesterase inhibitors may increase phosphorylated tau in Alzheimer's disease.

Cholinesterase inhibitors may increase phosphorylated tau in Alzheimer's disease.

Cholinesterase inhibitors (ChEIs) are widely used for the symptomatic treatment of Alzheimer's disease (AD). In vitro and in animal studies, ChEIs have been shown to influence the processing of Abeta and the phosphorylation of tau, proteins that are the principal constituents of the plaques and...

पूर्ण विवरण

ग्रंथसूची विवरण
मुख्य लेखकों:	Chalmers, K, Wilcock, G, Vinters, H, Perry, E, Perry, R, Ballard, C, Love, S
स्वरूप:	Journal article
भाषा:	English
प्रकाशित:	2009

समान संसाधन

Cholinesterase inhibitor treatment increases phosphotau accumulation in Alzheimer's disease but reduces A beta in dementia with Lewy bodies
द्वारा: Chalmers, K, और अन्य
प्रकाशित: (2008)

Cholinesterase inhibitors reduce cortical Abeta in dementia with Lewy bodies.
द्वारा: Ballard, C, और अन्य
प्रकाशित: (2007)

The pharmacological treatment of Alzheimer's disease with cholinesterase inhibitors and memantine
द्वारा: Wilcock, G
प्रकाशित: (2007)

Loss of perineuronal nets in Alzheimer's disease is not related to tau pathology
द्वारा: Baig, S, और अन्य
प्रकाशित: (2004)

Epigenetic Modulation on Tau Phosphorylation in Alzheimer’s Disease
द्वारा: Chao-Chao Yu, और अन्य
प्रकाशित: (2019-01-01)

MMP-3 and-9 may degrade the perineuronal net but their activity is not increased in frontal cortex in Alzheimer's disease
द्वारा: Baig, S, और अन्य
प्रकाशित: (2006)

Electrocardiographic Effects of Cholinesterase Inhibitors in Patients with Alzheimer’s Disease
द्वारा: Ayşe ÇOLAK, और अन्य
प्रकाशित: (2022-12-01)

Structure Based Design and Molecular Docking Studies for Phosphorylated Tau Inhibitors in Alzheimer’s Disease
द्वारा: Jangampalli Adi Pradeepkiran, और अन्य
प्रकाशित: (2019-03-01)

Contributors to white matter damage in Alzheimer's disease
द्वारा: Chalmers, K, और अन्य
प्रकाशित: (2005)

Absence of a Role for Phosphorylation in the Tau Pathology of Alzheimer’s Disease
द्वारा: Robert Y. K. Lai, और अन्य
प्रकाशित: (2016-04-01)

Contributors to white matter damage in the frontal lobe in Alzheimer's disease.
द्वारा: Chalmers, K, और अन्य
प्रकाशित: (2005)

The effect of cholinesterase inhibitors in AD: A class act?
द्वारा: Wilcock, G
प्रकाशित: (2004)

Odor identification impairment and cholinesterase inhibitor treatment in Alzheimer's disease
द्वारा: Jeffrey N. Motter, और अन्य
प्रकाशित: (2021-01-01)

CHRNA7 polymorphisms and response to cholinesterase inhibitors in Alzheimer's disease.
द्वारा: Pei-Hsuan Weng, और अन्य
प्रकाशित: (2013-01-01)

Cholinesterase inhibitors influence APP metabolism in Alzheimer disease patients
द्वारा: Martina Zimmermann, और अन्य
प्रकाशित: (2005-06-01)

Synthesis and Biological Evaluation of New Cholinesterase Inhibitors for Alzheimer’s Disease
द्वारा: Weiam Hussein, और अन्य
प्रकाशित: (2018-08-01)

Fully synthetic phosphorylated Tau181, Tau217, and Tau231 calibrators for Alzheimer’s disease diagnosis
द्वारा: Xinyu Li, और अन्य
प्रकाशित: (2024-01-01)

Phosphorylation of different tau sites during progression of Alzheimer’s disease
द्वारा: Joerg Neddens, और अन्य
प्रकाशित: (2018-06-01)

Relationship of neurofibrillary pathology to cerebral amyloid angiopathy in Alzheimer's disease.
द्वारा: Williams, S, और अन्य
प्रकाशित: (2005)

Relationship of neurofibrillary pathology to cerebral amyloid angiopathy in Alzheimer's disease
द्वारा: Williams, S, और अन्य
प्रकाशित: (2005)

Amyloid-beta and phosphorylated tau in post-mortem Alzheimer’s disease retinas
द्वारा: Jurre den Haan, और अन्य
प्रकाशित: (2018-12-01)

Exploring Mannosylpurines as Copper Chelators and Cholinesterase Inhibitors with Potential for Alzheimer’s Disease
द्वारा: Ignazio Schino, और अन्य
प्रकाशित: (2022-12-01)

Functional response to cholinesterase inhibitor therapy in a naturalistic Alzheimer’s disease cohort
द्वारा: Wattmo Carina, और अन्य
प्रकाशित: (2012-11-01)

APOE epsilon 4 favours vascular over parenchymal deposition of A beta protein in Alzheimer's disease
द्वारा: Chalmers, K, और अन्य
प्रकाशित: (2002)

The regulation of tau phosphorylation by PCTAIRE 3: Implications for the pathogenesis of Alzheimer's disease
द्वारा: A.Z. Herskovits, और अन्य
प्रकाशित: (2006-08-01)

Pin1 colocalization with phosphorylated tau in Alzheimer's disease and other tauopathies
द्वारा: Pankajavalli Ramakrishnan, और अन्य
प्रकाशित: (2003-11-01)

Propofol directly increases tau phosphorylation.
द्वारा: Robert A Whittington, और अन्य
प्रकाशित: (2011-01-01)

Longitudinal plasma phosphorylated tau 181 tracks disease progression in Alzheimer’s disease
द्वारा: Shi-Dong Chen, और अन्य
प्रकाशित: (2021-06-01)

APOE epsilon 4 influences the pathological phenotype of Alzheimer's disease by favouring cerebrovascular over parenchymal accumulation of A beta protein.
द्वारा: Chalmers, K, और अन्य
प्रकाशित: (2003)

Memantine and cholinesterase inhibitor combination therapy for Alzheimer's disease: a systematic review
द्वारा: Farrimond, L, और अन्य
प्रकाशित: (2012)

Derivatives of Amodiaquine as Potent Human Cholinesterases Inhibitors: Implication for Treatment of Alzheimer’s Disease
द्वारा: Ana Matošević, और अन्य
प्रकाशित: (2024-11-01)

The effect of cholinesterase inhibitors on sleep in the patients with Alzheimer’s disease: an observational prospective study
द्वारा: Osman Korucu, और अन्य
प्रकाशित: (2018-01-01)

Amyloid Beta and Phosphorylated Tau-Induced Defective Autophagy and Mitophagy in Alzheimer’s Disease
द्वारा: P. Hemachandra Reddy, और अन्य
प्रकाशित: (2019-05-01)

Comprehensive Characterization of CK1δ-Mediated Tau Phosphorylation in Alzheimer’s Disease
द्वारा: Aileen Roth, और अन्य
प्रकाशित: (2022-06-01)

Phosphorylated Tau 181 Serum Levels Predict Alzheimer’s Disease in the Preclinical Stage
द्वारा: Wei Qin, और अन्य
प्रकाशित: (2022-06-01)

The Role of MicroRNAs in Aβ Deposition and Tau Phosphorylation in Alzheimer’s Disease
द्वारा: Juanjuan Zhao, और अन्य
प्रकाशित: (2017-07-01)

Loss of biliverdin reductase-A favors Tau hyper-phosphorylation in Alzheimer's disease
द्वारा: Nidhi Sharma, और अन्य
प्रकाशित: (2019-05-01)

CSF total tau/α-synuclein ratio improved the diagnostic performance for Alzheimer’s disease as an indicator of tau phosphorylation
द्वारा: Kyu Hwan Shim, और अन्य
प्रकाशित: (2020-07-01)

HYPERINSULINEMIA AFFECTS TAU PHOSPHORYLATION IN PREDIABETIC ALZHEIMER´S DIASESE MICE
द्वारा: Monica Garcia-Alloza, और अन्य
प्रकाशित: (2023-10-01)

Cholinesterase inhibition for Alzheimer disease: a meta-analysis of the tacrine trials. Dementia Trialists' Collaboration.
द्वारा: Qizilbash, N, और अन्य
प्रकाशित: (1998)